Demographics, treatment patterns and clinical outcomes in ROS1-positive non-small cell lung cancer: A referral tertiary cancer centre experience from a low-middle income country

被引：0
|
作者：
Panda, G. S. [1 ]
Noronha, V. [1 ]
Patil, V. M. [1 ]
Joshi, A. P. [1 ]
Menon, N. S. [1 ]
Singh, A. C. [1 ]
Kumar, R. [2 ]
Pai, T. [2 ]
Shetty, O. [2 ]
Janu, A. [3 ]
Chakrabarty, N. [3 ]
Purandare, N. [4 ]
Dey, S. [1 ]
Prabhash, K. [1 ]
机构：
[1] Tata Mem Hosp, Tata Mem Ctr, Med Oncol, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Tata Mem Ctr, Pathol, Mumbai, Maharashtra, India
[3] Tata Mem Hosp, Tata Mem Ctr, Radiol, Mumbai, Maharashtra, India
[4] Tata Mem Hosp, Tata Mem Ctr, Bioimaging, Mumbai, Maharashtra, India
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
391P
引用
收藏
页码：S1594 / S1595
页数：2
相关论文
共 50 条
  • [1] Clinical outcomes of ROS1-positive non-small cell lung cancer with limited access to ROS1-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centre
    Panda, Goutam Santosh
    Noronha, Vanita
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Kumar, Rajiv
    Pai, Trupti
    Shetty, Omshree
    Janu, Amit
    Chakrabarty, Nivedita
    Purandare, Nilendu
    Dey, Sayak
    Prabhash, Kumar
    ECANCERMEDICALSCIENCE, 2024, 18
  • [2] LORLATINIB IS ACTIVE IN ROS1-POSITIVE NON-SMALL CELL LUNG CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (01) : 12 - 12
  • [3] Treatment Patterns and Clinical Outcomes in Locally Advanced Non Small Cell Lung Cancer: Experience from Tertiary Care Centre
    Pathy, S.
    Thimmarayappa, A.
    Malik, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1106 - S1107
  • [4] Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice
    Park, Sehhoon
    Ahn, Beung-Chul
    Lim, Sung Won
    Sun, Jong-Mu
    Kim, Hye Ryun
    Hong, Min Hee
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    La Choi, Yoon
    Cho, Byoung Chul
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1373 - 1382
  • [5] Timing And Accuracy Of Clinical Staging of Non-Small Cell Lung Cancer in a Tertiary Lung Cancer Referral Centre
    Brien, S. O.
    Dalton, B.
    Edwards, L.
    Nicholson, S.
    Ryan, R.
    Young, V.
    Fitzmaurice, G.
    O'Connell, F.
    Nadarajan, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S23 - S24
  • [6] Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer
    Zhu, You-Cai
    Zhang, Xin-Gen
    Lin, Xue-Ping
    Wang, Wen-Xian
    Li, Xiao-Feng
    Wu, Li-Xin
    Chen, Hua-Fei
    Xu, Chun-Wei
    Du, Kai-Qi
    ONCOLOGY LETTERS, 2019, 17 (03) : 3466 - 3474
  • [7] Ceritinib in ROS1-positive non-small cell lung cancer patients: does clinical evidence carry clinical impact?
    Facchinetti, Francesco
    Tiseo, Marcello
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1074 - S1079
  • [8] ALK TRANSLOCATED NON-SMALL CELL LUNG CANCER: EXPERIENCE FROM AN AUSTRALIAN METROPOLITAN TERTIARY REFERRAL CENTRE
    Itchins, Malinda
    Sinn, Kate
    Chan, David
    Crumbaker, Megan
    Gill, Anthony
    Clarke, Stephen
    Pavlakis, Nick
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 174 - 175
  • [9] Detection of ROS1-positive non-small cell lung cancer on cytological specimens using immunocytochemistry
    Vlajnic, Tatjana
    Savic, Spasenija
    Barascud, Audrey
    Baschiera, Betty
    Bihl, Michel
    Grilli, Bruno
    Herzog, Michelle
    Rebetez, Julien
    Bubendorf, Lukas
    CANCER CYTOPATHOLOGY, 2018, 126 (06) : 421 - 429
  • [10] ROS1-Positive Non-Small Cell Lung Cancer: Real-World Data in Korea
    Ahn, B. C.
    Park, S.
    Lim, S. W.
    Kim, H. R.
    Hong, M. H.
    Cho, B. C.
    Ahn, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S458 - S458
12345